Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis.
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.
Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
Altered cognitive-emotional behavior in early experimental autoimmune encephalitis - Cytokine and hormonal correlates.
Teriflunomide in relapsing multiple sclerosis: therapeutic utility.
Warmer outdoor temperature is associated with task-related increased BOLD activation in patients with multiple sclerosis.
Implication of matrix metalloproteinases in regulating neuronal disorder.
Actively Induced Experimental Autoimmune Encephalomyelitis in Rats.
Th17 cells in autoimmune diseases.
A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treating.
Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.
Natalizumab SC Similar to IV Every 4 Weeks for MS
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
Plasma exchange response in 34 patients with severe optic neuritis.
Transcranial Direct Current Stimulation Is Feasible for Remotely Supervised Home Delivery in Multiple Sclerosis.
Optic neuritis in an adult patient with chickenpox.
Chronic cerebrospinal venous insufficiency in multiple sclerosis: A sonographer-blinded case-control study.
Erratum to: Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Pages
« first
‹ previous
…
642
643
644
645
646
647
648
649
650
…
next ›
last »